Doina Istrătescu

531 total citations
18 papers, 87 citations indexed

About

Doina Istrătescu is a scholar working on Epidemiology, Genetics and Hepatology. According to data from OpenAlex, Doina Istrătescu has authored 18 papers receiving a total of 87 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Genetics and 6 papers in Hepatology. Recurrent topics in Doina Istrătescu's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Doina Istrătescu is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Doina Istrătescu collaborates with scholars based in Romania, Belgium and United States. Doina Istrătescu's co-authors include Carmen Monica Preda, Mircea Mănuc, Mircea Diculescu, Cristian Tieranu, Cristian Băicuş, Édouard Louis, Theodor Voiosu, Adina Croitoru, Corina Silvia Pop and Anca Trifan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nutrients and Medicine.

In The Last Decade

Doina Istrătescu

16 papers receiving 87 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doina Istrătescu Romania 5 45 32 31 18 13 18 87
Г. В. Волынец Russia 7 42 0.9× 23 0.7× 43 1.4× 24 1.3× 7 0.5× 57 109
Jamilya Kaibullayeva Kazakhstan 4 59 1.3× 17 0.5× 25 0.8× 3 0.2× 6 0.5× 9 79
Floris F. van den Brand Netherlands 4 68 1.5× 65 2.0× 23 0.7× 3 0.2× 6 0.5× 8 101
James Markowitz United States 4 66 1.5× 18 0.6× 20 0.6× 55 3.1× 56 4.3× 15 108
Begoña Sacristán Spain 4 34 0.8× 37 1.2× 4 0.1× 23 1.3× 6 0.5× 5 113
Maria Cappello Italy 2 37 0.8× 9 0.3× 44 1.4× 8 0.4× 5 0.4× 4 45
Niviann Blondet United States 5 32 0.7× 28 0.9× 9 0.3× 5 0.4× 12 68
Ömer Faruk Beșer Türkiye 6 12 0.3× 4 0.1× 10 0.3× 11 0.6× 9 0.7× 13 132
HE Drummond United Kingdom 3 61 1.4× 4 0.1× 83 2.7× 15 0.8× 9 0.7× 5 114
Izumi Tsunematsu Japan 5 31 0.7× 43 1.3× 3 0.1× 11 0.6× 10 0.8× 6 68

Countries citing papers authored by Doina Istrătescu

Since Specialization
Citations

This map shows the geographic impact of Doina Istrătescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doina Istrătescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doina Istrătescu more than expected).

Fields of papers citing papers by Doina Istrătescu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doina Istrătescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doina Istrătescu. The network helps show where Doina Istrătescu may publish in the future.

Co-authorship network of co-authors of Doina Istrătescu

This figure shows the co-authorship network connecting the top 25 collaborators of Doina Istrătescu. A scholar is included among the top collaborators of Doina Istrătescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doina Istrătescu. Doina Istrătescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Istrătescu, Doina, et al.. (2025). The Importance of Nutriepigenetics in Older Adults with Inflammatory Bowel Disease. Nutrients. 17(4). 620–620. 1 indexed citations
2.
Istrătescu, Doina, et al.. (2025). Artificial Intelligence as a Tool in Diagnosing Inflammatory Bowel Disease in Older Adults. Journal of Clinical Medicine. 14(4). 1360–1360.
3.
Preda, Carmen Monica, et al.. (2024). Sylimarin Versus Essential Phospholipids in Metabolic Associated Steatotic Liver Disease (MASLD) – A Prospective Comparative Randomized Trial. MAEDICA – a Journal of Clinical Medicine. 1(1). 9–16. 3 indexed citations
4.
Preda, Carmen Monica, et al.. (2024). P1003 Dietary pattern can influence the level of fatigue in patients with Inflammatory Bowel Disease in remission. Journal of Crohn s and Colitis. 18(Supplement_1). i1807–i1807. 1 indexed citations
5.
Preda, Carmen Monica, Doina Istrătescu, Mircea Mănuc, et al.. (2024). Diet Optimization in Inflammatory Bowel Disease: Impact on Disease Relapse and Inflammatory Markers. A 1-year Prospective Trial. Journal of Gastrointestinal and Liver Diseases. 33(2). 184–193. 3 indexed citations
6.
Istrătescu, Doina, et al.. (2024). A Comprehensive Review of Dietary Approaches in Maintaining Remission of Inflammatory Bowel Diseases in Adults. Medicina. 60(7). 1068–1068. 2 indexed citations
7.
Preda, Carmen Monica, et al.. (2023). Anxiety and depression in patients with inactive inflammatory bowel disease: The role of fatigue and health-related quality of life. Medicine. 102(19). e33713–e33713. 8 indexed citations
8.
Preda, Carmen Monica, Doina Istrătescu, Mircea Mănuc, et al.. (2023). Fatigue Is Associated with Anxiety and Lower Health-Related Quality of Life in Patients with Inflammatory Bowel Disease in Remission. Medicina. 59(3). 532–532. 4 indexed citations
10.
Gheorghe, Liana, Carmen Monica Preda, Anca Trifan, et al.. (2022). Real World Efficacy and Safety of Sofosbuvir + Velpatasvir + Voxilaprevir in Romanian Patients with Genotype 1b HCV Infection Non-reponders to DAAs Therapy. Journal of Gastrointestinal and Liver Diseases. 31(4). 437–443. 2 indexed citations
11.
Preda, Carmen Monica, Doina Istrătescu, Mircea Mănuc, et al.. (2022). HLA Genotyping in Romanian Adult Patients with Celiac Disease, their First-degree Relatives and Healthy Persons. Journal of Gastrointestinal and Liver Diseases. 31(2). 191–197. 3 indexed citations
12.
Mănuc, Mircea, Carmen Monica Preda, Laura Iliescu, et al.. (2021). Efficacy of treatment with Ombitasvir, Paritaprevir / r + Dasabuvir over 8 versus 12 weeks in chronic HCV hepatitis genotype 1B. SHILAP Revista de lepidopterología. 24(1). 44–50. 4 indexed citations
13.
Pop, Corina Silvia, Carmen Monica Preda, Mircea Mănuc, et al.. (2020). Occurrence and recurrence of hepatocellular carcinoma in patients with HCV genotype 1b related cirrhosis treated with Ledipasvir + Sofosbuvir ± Ribavirin. Journal of Gastrointestinal and Liver Diseases. 29(4). 690–691. 3 indexed citations
14.
Gheorghe, Liliana, Laura Iliescu, Doina Istrătescu, et al.. (2020). Efficacy and Safety of Ledispavir/Sofosbuvir with or without Ribavirin in patients with Decompensated Liver Cirrhosis and Hepatitis C Infection: a Cohort Study. Journal of Gastrointestinal and Liver Diseases. 29(3). 385–390. 9 indexed citations
15.
Preda, Carmen Monica, Doina Istrătescu, Édouard Louis, et al.. (2020). Diet as an environmental trigger in inflammatory bowel disease: a retrospective comparative study in two European cohorts. Revista Española de Enfermedades Digestivas. 112(6). 440–447. 18 indexed citations
16.
Preda, Carmen Monica, Cristian Băicuş, Ileana Constantinescu, et al.. (2019). Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus‐associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy. United European Gastroenterology Journal. 7(5). 699–708. 16 indexed citations
17.
Becheanu, Gabriel, Doina Istrătescu, Carmen Monica Preda, et al.. (2019). Lymphocytic Esophagitis Successfully Treated by Esophageal Balloon Dilation and Topical Budesonide. Journal of Gastrointestinal and Liver Diseases. 28(4). 379–379. 1 indexed citations
18.
Becheanu, Gabriel, et al.. (2019). P047 Neuroendocrine cells densities alterations in colonic mucosa of patients with inflammatory bowel disease. Journal of Crohn s and Colitis. 13(Supplement_1). S110–S110.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026